Stereotaxis Inc  

(Public, NASDAQ:STXS)   Watch this stock  
Find more results for Fred Mills
1.30
0.00 (0.34%)
Real-time:   10:28AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.24 - 1.33
52 week 0.54 - 2.53
Open 1.33
Vol / Avg. 2,569.00/96,642.00
Mkt cap 28.38M
P/E     -
Div/yield     -
EPS -0.30
Shares 21.76M
Beta 3.00
Inst. own 27%
Aug 2, 2016
Q2 2016 Stereotaxis Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 9, 2016
Q1 2016 Stereotaxis Inc Earnings Call - Webcast
May 9, 2016
Q1 2016 Stereotaxis Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -26.30% -19.52%
Operating margin -17.19% -14.36%
EBITD margin - -12.72%
Return on average assets -53.02% -34.11%
Return on average equity - -
Employees 133 -
CDP Score - -

Address

4320 Forest Park Ave Ste 100
ST. LOUIS, MO 63108-2979
United States - Map
+1-314-6786100 (Phone)
+1-314-6786159 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Stereotaxis, Inc. designs, manufactures and markets robotic systems and instruments for use by electrophysiologists for the treatment of abnormal heart rhythms known as cardiac arrhythmias. The Company offers its Epoch Solution, a remote robotic navigation system for use in a hospital's interventional surgical suite or interventional lab. The Epoch Solution consists of the Niobe ES Robotic Magnetic Navigation System (Niobe ES system), Odyssey Information Management Solution (Odyssey Solution) and the Vdrive Robotic Navigation System (Vdrive system), and related devices. Its Niobe ES System provides physicians with remote digital instrument control through computer mouse control, in combination with image integration and three-dimensional reconstruction. The Odyssey Solution offers an information solution to manage, control, record and share procedures across networks or around the world. The Vdrive system provides navigation and stability for diagnostic and ablation devices.

Officers and directors

William C. Mills III Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Martin C. Stammer Chief Financial Officer, IR Contact Officer
Age: 34
Bio & Compensation  - Reuters
Susan S. Lanigan Executive Vice President, General Counsel
Age: 51
Bio & Compensation  - Reuters
Frank J. Cheng Senior Vice President - Marketing and Business Development
Age: 47
Bio & Compensation  - Reuters
Karen W. Duros Senior Vice President, Secretary
Age: 60
Bio & Compensation  - Reuters
David A. Giffin Vice President - Human Resources
Age: 66
Bio & Compensation  - Reuters
Duane M. DeSisto Director
Age: 60
Bio & Compensation  - Reuters
David W. Benfer Independent Director
Age: 69
Bio & Compensation  - Reuters
Joseph D. Keegan Ph.D. Independent Director
Age: 61
Bio & Compensation  - Reuters
Robert J. Messey Independent Director
Age: 69
Bio & Compensation  - Reuters